English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This review considers current variants of immunotherapy in patients with disseminated renal cell carcinoma. Data from experimental studies concerning defects in immunocompetent cells and mechanisms that block the normal immune response in patients with tumors are presented. Data of completed clinical trials of blockers of co-inhibiting molecules and cytokines in patients with renal cell carcinoma are analyzed.

Immunotherapy of renal cell carcinoma: Current state of the problem and promising areas of research